#news #biotech Newly discovered biosynthetic pathway in bacteria recipe for drug discovery and production

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Newly discovered biosynthetic pathway in bacteria recipe for drug discovery and production .Microbes are master chefs of the biomolecular world; collectively, they harbor the ability to produce a vast array of unknown substances, some of which may have therapeutic or other useful properties. In searching for useful products, a team of chemists at Illinois have discovered a whole new class of microbial recipes.

from Biotechnology News – Biology News https://ift.tt/2Gng6Qq

#news #biotech NASH-linked gene discovery could inspire new drugs to treat liver damage

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: NASH-linked gene discovery could inspire new drugs to treat liver damage .A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in patients with nonalcoholic steatohepatitis (NASH). They believe the finding will inspire new treatments to prevent liver damage in those patients.

from FierceBiotech: Biotech https://ift.tt/2JFE3nV

#news #biotech Novartis licenses out early antiviral work to Gilead

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novartis licenses out early antiviral work to Gilead .Just two days after announcing its R&D chief was stepping down, Gilead Sciences has announced it will be buying up a few of Novartis’ unwanted early-stage infection assets.

from FierceBiotech: Biotech https://ift.tt/2JSRJe2

#news #biotech Chutes & Ladders—Gilead CEO continues top-level revamp with 3 more exec exits

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes & Ladders—Gilead CEO continues top-level revamp with 3 more exec exits .Gilead CEO continues top-level revamp with three more exec exits; GSK snares ex-Novartis, AZ CFO as chairman; and Immusoft names former Amgen biologics head as CSO. Those moves plus more hirings, firings and retirings throughout the industry.

from FierceBiotech: Biotech https://ift.tt/2JUutML

#news #biotech How a faulty gene that drives muscular dystrophy also shields cancer cells from immunotherapy

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: How a faulty gene that drives muscular dystrophy also shields cancer cells from immunotherapy .A team at the Fred Hutchinson Cancer Research Center has discovered that the mechanisms that activate the normally silenced gene DUX4 in a type of muscular dystrophy also help some cancer cells evade immune checkpoint inhibitors.

from FierceBiotech: Biotech https://ift.tt/2JRITgK

#news #biotech New genome editing technology for plant breeding

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New genome editing technology for plant breeding .Researchers have developed a new genome editing technology for rice, combining adenine-to-guanine single-base editing technology and Cas9 with an extended targeting scope. They report that it is possible to efficiently introduce base substitution mutations in rice genes and plan to expand the research to citrus fruit breeding.

from Biotechnology News – Biology News https://ift.tt/30FGJHN

#news #biotech Peanut plant’s ‘chemical breath’ could give clues to drought and other stresses

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Peanut plant’s ‘chemical breath’ could give clues to drought and other stresses .Peanut growers could someday identify emerging threats such as drought, pests or disease by testing a plant’s “chemical breath.”

from Biotechnology News – Biology News https://ift.tt/2YYQpNa

#news #biotech Helping robots to build new antibiotics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Helping robots to build new antibiotics .A team from The University of Manchester have engineered a common gut bacterium to produce a new class of antibiotics by using robotics. These antibiotics, known as class II polyketides, are also naturally produced by soil bacteria and have antimicrobial properties which are vital in the modern pharmaceutical industry to combat infectious diseases and cancer.

from Biotechnology News – Biology News https://ift.tt/2SqqUlG

#news #biotech J&J, Novartis help Medicxi raise €400M biopharma fund

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: J&J, Novartis help Medicxi raise €400M biopharma fund .Medicxi has raised a €400 million ($448 million) biopharma investment fund. Johnson & Johnson and Novartis pumped money into the fund as cornerstone strategic investors, helping Medicxi wrap up fundraising in record time.

from FierceBiotech: Biotech https://ift.tt/2LYoHMR